Cargando…

CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis

BACKGROUND: CXCR4, a transmembrane-receptor located on epithelial cells that is activated by CXCL12, may have a role in IPF via migration of CXCR4(+) fibrocytes to the lung. However, its expression has not been fully characterised in idiopathic pulmonary fibrosis (IPF) or other fibrotic interstitial...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffar, Jade, Griffiths, Kate, Oveissi, Sara, Duan, Mubing, Foley, Michael, Glaspole, Ian, Symons, Karen, Organ, Louise, Westall, Glen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449054/
https://www.ncbi.nlm.nih.gov/pubmed/32843095
http://dx.doi.org/10.1186/s12931-020-01467-0
_version_ 1783574596014833664
author Jaffar, Jade
Griffiths, Kate
Oveissi, Sara
Duan, Mubing
Foley, Michael
Glaspole, Ian
Symons, Karen
Organ, Louise
Westall, Glen
author_facet Jaffar, Jade
Griffiths, Kate
Oveissi, Sara
Duan, Mubing
Foley, Michael
Glaspole, Ian
Symons, Karen
Organ, Louise
Westall, Glen
author_sort Jaffar, Jade
collection PubMed
description BACKGROUND: CXCR4, a transmembrane-receptor located on epithelial cells that is activated by CXCL12, may have a role in IPF via migration of CXCR4(+) fibrocytes to the lung. However, its expression has not been fully characterised in idiopathic pulmonary fibrosis (IPF) or other fibrotic interstitial lung diseases (ILDs). CXCL12 is constitutively expressed in the bone marrow, and levels of CXCR4 regulate control of this signalling pathway. The aim of this study was to profile the expression of CXCR4 in lung tissue and peripheral circulation of patients with IPF and other fibrotic ILDs. METHODS: Expression of CXCR4 on peripheral blood mononuclear cells (PBMCs) was examined by flow cytometry in 20 patients with IPF and 10 age-matched non-disease control (NDC) donors. Levels of CXCL12 in human plasma were measured by ELISA. Expression of CXCR4, CXCL12, CD45, and e-cadherin was assessed in IPF (n = 10), other fibrotic ILD (n = 8) and NDC (n = 10) lung tissue by multiplex immunohistochemistry (OPAL) and slides were scanned using a Vectra 3 scanner. Cells were quantified with computer automated histological analysis software (HALO). RESULTS: In blood, the number of CXCR4(+) cells was lower but the level of CXCL12 was higher in patients with IPF compared to NDC donors. Elevated CXCR4 expression was detected in lung tissue from patients with IPF and other fibrotic ILDs compared to NDC. There were higher levels of CXCR4(+)/e-cadherin(+)/CXCL12(+) (epithelial) cells in IPF lung tissue compared to NDC, but there was no difference in the numbers of CXCR4(+)/CD45(+)/CXCL12(+) (myeloid) cells between the two groups. CONCLUSIONS: This report demonstrates that CXCR4 is overexpressed not only in IPF but also in other ILDs and expression is particularly prominent within both honeycomb cysts and distal airway epithelium. This observation supports the hypothesis that CXCR4 may drive tissue fibrosis through binding its specific ligand CXCL12. Although CXCR4 expressing cells could be either of epithelial or myeloid origin it appears that the former is more prominent in IPF lung tissue. Further characterization of the cells of the honeycomb cyst may lead to a better understanding of the fibrogenic processes in IPF and other end-stage fibrotic ILDs.
format Online
Article
Text
id pubmed-7449054
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74490542020-08-27 CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis Jaffar, Jade Griffiths, Kate Oveissi, Sara Duan, Mubing Foley, Michael Glaspole, Ian Symons, Karen Organ, Louise Westall, Glen Respir Res Research BACKGROUND: CXCR4, a transmembrane-receptor located on epithelial cells that is activated by CXCL12, may have a role in IPF via migration of CXCR4(+) fibrocytes to the lung. However, its expression has not been fully characterised in idiopathic pulmonary fibrosis (IPF) or other fibrotic interstitial lung diseases (ILDs). CXCL12 is constitutively expressed in the bone marrow, and levels of CXCR4 regulate control of this signalling pathway. The aim of this study was to profile the expression of CXCR4 in lung tissue and peripheral circulation of patients with IPF and other fibrotic ILDs. METHODS: Expression of CXCR4 on peripheral blood mononuclear cells (PBMCs) was examined by flow cytometry in 20 patients with IPF and 10 age-matched non-disease control (NDC) donors. Levels of CXCL12 in human plasma were measured by ELISA. Expression of CXCR4, CXCL12, CD45, and e-cadherin was assessed in IPF (n = 10), other fibrotic ILD (n = 8) and NDC (n = 10) lung tissue by multiplex immunohistochemistry (OPAL) and slides were scanned using a Vectra 3 scanner. Cells were quantified with computer automated histological analysis software (HALO). RESULTS: In blood, the number of CXCR4(+) cells was lower but the level of CXCL12 was higher in patients with IPF compared to NDC donors. Elevated CXCR4 expression was detected in lung tissue from patients with IPF and other fibrotic ILDs compared to NDC. There were higher levels of CXCR4(+)/e-cadherin(+)/CXCL12(+) (epithelial) cells in IPF lung tissue compared to NDC, but there was no difference in the numbers of CXCR4(+)/CD45(+)/CXCL12(+) (myeloid) cells between the two groups. CONCLUSIONS: This report demonstrates that CXCR4 is overexpressed not only in IPF but also in other ILDs and expression is particularly prominent within both honeycomb cysts and distal airway epithelium. This observation supports the hypothesis that CXCR4 may drive tissue fibrosis through binding its specific ligand CXCL12. Although CXCR4 expressing cells could be either of epithelial or myeloid origin it appears that the former is more prominent in IPF lung tissue. Further characterization of the cells of the honeycomb cyst may lead to a better understanding of the fibrogenic processes in IPF and other end-stage fibrotic ILDs. BioMed Central 2020-08-26 2020 /pmc/articles/PMC7449054/ /pubmed/32843095 http://dx.doi.org/10.1186/s12931-020-01467-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jaffar, Jade
Griffiths, Kate
Oveissi, Sara
Duan, Mubing
Foley, Michael
Glaspole, Ian
Symons, Karen
Organ, Louise
Westall, Glen
CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis
title CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis
title_full CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis
title_fullStr CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis
title_full_unstemmed CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis
title_short CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis
title_sort cxcr4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449054/
https://www.ncbi.nlm.nih.gov/pubmed/32843095
http://dx.doi.org/10.1186/s12931-020-01467-0
work_keys_str_mv AT jaffarjade cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT griffithskate cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT oveissisara cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT duanmubing cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT foleymichael cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT glaspoleian cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT symonskaren cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT organlouise cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis
AT westallglen cxcr4cellsareincreasedinlungtissueofpatientswithidiopathicpulmonaryfibrosis